Joshua A. Kazam
2010
In 2010, Joshua A. Kazam earned a total compensation of $16.9K as President & CEO at Capricor Therapeutics, a 79% decrease compared to previous year.
Compensation breakdown
| Option Awards | $16,876 |
|---|---|
| Total | $16,876 |
Kazam received $16.9K in option awards, accounting for 100% of the total pay in 2010.
Rankings
In 2010, Joshua A. Kazam's compensation ranked 10,402nd out of 10,439 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,402 out of 10,439 | 0th |
Division Manufacturing | 3,829 out of 3,838 | 0th |
Major group Chemicals And Allied Products | 923 out of 926 | 0th |
Industry group Drugs | 685 out of 685 | 0th |
Industry Pharmaceutical Preparations | 481 out of 481 | 0th |
Source: SEC filing on April 8, 2011.
Kazam's colleagues
We found two more compensation records of executives who worked with Joshua A. Kazam at Capricor Therapeutics in 2010.